Chris O'Brien
Few & Far Between: Conversations from the Front Lines of Drug Development
Erleben Sie Chris O'Brien im Gespräch mit Experten aus Forschung, Biotechnologie und Politik, die Einblicke in die Arzneimittelentwicklung teilen.
Episode 54, Part One: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics
S5 E54 • 45 mins • May 28, 2025
Charts
- 163Decreased by 18
- 186Increased by 0
- 189Decreased by 53
- 200Decreased by 44
- 134Increased by 0
Neueste Folgen

May 28, 2025
Episode 54, Part One: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics
S5 E54 • 45 mins

Apr 29, 2025
Episode 53: Frank David, Founder and Managing Director, Pharmagellan
S5 E53 • 51 mins

Apr 23, 2025
Episode 52: Joshua Kresh, Emily Michiko Morris, and Mark Schultz, IPPI
S5 E52 • 52 mins

Apr 3, 2025
Episode 51: Dan Oliver, CEO and Founder, Rejuvenate Bio
S5 E51 • 55 mins

Mar 18, 2025
Epsiode 50: Jonathan Rigby, Chairman and CEO, Sernova
S5 E50 • 52 mins

Sprache
Englisch
Land
Vereinigte Staaten
Feed Host
Website
Feed
Aktualisierung anfordern
Aktualisierungen können einige Minuten dauern.